Selecting a nutraceutical ingredient is not only a question of assay or active content. The ingredient also has to survive manufacturing, remain compatible with the rest of the formulation, behave predictably during storage and fit the intended dosage form.
This is where microencapsulation can become useful.
In food and nutraceutical applications, microencapsulation places an active material within or around a protective matrix or coating. Depending on the active, wall material and manufacturing process, this approach can help protect sensitive compounds from environmental stress, improve handling, manage undesirable taste or odour and convert certain oils into dry powder formats.[1,2,3]
The important point for formulators is that microencapsulation is not automatically a modified-release technology. Some encapsulation systems described in the scientific literature can be designed to alter release, but protection and release modification are separate technical objectives. The current NexaGens microencapsulated ingredient range is designed as immediate/non-modified release, with the matrix used for protection and handling rather than intentional release delay.[4]
What is microencapsulation?
Microencapsulation is a formulation technique in which an active material is embedded within, surrounded by or associated with another material that forms a protective structure around it.[1,2]
The active is commonly called the core material, while the surrounding material may be described as the matrix, wall, shell or coating.
The structure varies considerably depending on the manufacturing method, active ingredient and required function. Food-grade encapsulation systems can use carbohydrates, proteins, lipids or combinations of materials.[1]
For a formulator, however, the most useful question is not simply:
“Is this ingredient microencapsulated?”
A better question is:
“What formulation problem is the encapsulation system intended to solve, and what data demonstrate that function?”
That distinction matters because two ingredients sold under the same broad term can perform very differently in a finished formulation.
Why is microencapsulation used in nutraceutical formulations?
Microencapsulation can address several formulation challenges, but the expected benefit should always be linked to the specific ingredient and encapsulation system.
Common objectives include:
- protecting sensitive actives against oxygen, light, heat or moisture;
- reducing undesirable taste or odour;
- converting liquid oils into more manageable dry powders;
- improving practical wetting or dispersibility;
- reducing direct interaction between incompatible ingredients; and
- improving powder handling or processability.[1,2,3]
These functions should not be treated as universal claims. An ingredient encapsulated mainly for oxidation protection, for example, should not automatically be assumed to provide taste masking, improved dispersibility or modified release.
1. Protecting sensitive nutraceutical ingredients
Many bioactive compounds can be affected by oxygen, light, heat, humidity or combinations of these environmental stresses. Microencapsulation can provide a physical barrier between the active ingredient and its surroundings, helping reduce exposure during processing and storage.[1,2]
This can be particularly relevant for oxidation- or light-sensitive ingredients such as carotenoids, certain oils and Coenzyme Q10.
Within the NexaGens portfolio, protective microencapsulation is used as one of the available approaches for ingredients where stability is a formulation concern.[5]
For a technical buyer, however, the word “protected” should never be enough on its own.
Useful questions to ask a supplier include:
- What stress conditions were used?
- Was the encapsulated ingredient compared with an unprotected reference?
- What temperature and relative humidity were used?
- Was light exposure defined?
- Which analytical method was used?
- Is real-time stability data available in addition to accelerated data?
A meaningful stability claim needs measurable evidence under defined conditions.
2. Managing taste and odour
Some nutraceutical ingredients introduce bitterness, metallic notes, strong aromas or other unwanted sensory characteristics.
Microencapsulation can help by reducing direct contact between the active material and the surrounding sensory environment. Scientific reviews identify flavour and odour masking among the established applications of encapsulation technologies in food systems.[1,3]
The result, however, depends on factors such as coating composition, encapsulation efficiency, particle size, processing conditions and the final dosage form.
A sensory result from a capsule formulation should not automatically be assumed to apply to a chewable tablet or beverage powder.
When taste masking is important, formulators should ask whether the supplier has actual sensory or application data rather than relying on a generic “taste-masked” description.
3. Converting oils into dry powders
One particularly useful application of microencapsulation is the conversion of certain liquid oils into dry powder formats.
Oil microencapsulation is widely studied because encapsulation can make oils easier to incorporate into dry systems and can help protect oxidation-sensitive lipid components from environmental exposure.[3]
For nutraceutical formulators, this can be relevant when working with ingredients such as omega-3 oils, algal DHA or certain essential oils.
However, total oil loading alone is not enough to evaluate an oil powder.
The amount of oil remaining exposed at the particle surface is also important because surface oil is more directly exposed to oxygen and can strongly influence stability and sensory performance.[3]
For oil powders, useful technical parameters can include:
- total oil content;
- surface oil;
- active fatty-acid or marker-compound content;
- peroxide value;
- anisidine value;
- TOTOX;
- moisture or water activity;
- particle-size distribution; and
- oxidation data over time.
NexaGens uses this same technical distinction when discussing oil-to-powder ingredients in its formulation platform.[8]
4. Supporting dispersibility and powder handling
Some nutraceutical ingredients are difficult to wet or disperse evenly.
An encapsulation matrix can sometimes change the physical behaviour of a powder and make it easier to distribute in a formulation or aqueous system.[1,2]
It is important, however, to distinguish dispersibility from true molecular solubility.
An ingredient can disperse more uniformly in water without the active itself becoming water-soluble.
For that reason, useful measurements can include:
- wettability;
- dispersion stability;
- sedimentation behaviour;
- reconstitution behaviour;
- content uniformity; and
- particle-size distribution.
NexaGens applies this same distinction to its technical discussion of solubility and dispersibility and does not treat improved dispersibility as an automatic bioavailability claim.[6]
5. Reducing unwanted ingredient interactions
Multi-ingredient formulations can create compatibility problems even when every individual raw material meets specification.
One ingredient can interact with another during storage, sometimes accelerating degradation, colour change or other undesirable effects.
Encapsulation can act as a physical-separation strategy by reducing direct contact between the protected active and neighbouring ingredients.[1]
For this type of claim, ingredient-level stability data are not always sufficient. The strongest evidence normally comes from a representative blend containing the ingredients expected to interact.
Within the NexaGens portfolio, microencapsulated iron ingredients are among the examples where physical matrix separation can be relevant to formulation design.[7]
When interaction protection is important, formulators should ask for blend-specific evidence and should consider whether the protective structure remains intact through mixing, compression, filling and storage.
Microencapsulation is not the same as modified release
This distinction deserves special attention.
The term microencapsulation describes a physical formulation approach. It does not, by itself, prove that an ingredient has sustained, delayed, enteric or controlled-release behaviour.
Some microencapsulation systems in published research are specifically engineered to modify release.[1,3] Others are used principally for protection, stability, sensory management or handling.
A release claim therefore requires its own evidence.
For NexaGens, the current microencapsulated range is explicitly positioned as immediate/non-modified release. Where intentional delayed or enteric release is required, that is treated as a different technology with different evidence requirements.[4]
Formulators should therefore avoid assuming that words such as “coated,” “encapsulated” or “protected” automatically mean delayed release.
If release behaviour is critical to the project, request appropriate dissolution or release-profile data from the supplier.
Which dosage forms can use microencapsulated ingredients?
Depending on the specific product, microencapsulated powders can be considered for applications such as:
- capsules;
- tablets;
- premixes;
- dry powder blends; and
- reconstitutable powder products.
Suitability depends on the individual ingredient, particle size, matrix composition, active loading and manufacturing conditions.
For example, tablet compression can create stresses that are very different from capsule filling. A material suitable for one process should therefore not automatically be assumed to be suitable for another.
The intended dosage form should be discussed with the ingredient supplier early in development.
How should formulators compare microencapsulated ingredients?
Comparing two microencapsulated ingredients only by active assay or price per kilogram can hide important differences in technical performance.
A stronger comparison begins with the function that the encapsulation is supposed to provide.
Depending on that objective, useful parameters can include:
- active assay;
- encapsulation efficiency;
- particle-size distribution;
- moisture or water activity;
- surface active or surface oil;
- dispersibility;
- bulk density;
- flow characteristics;
- microbiological specifications;
- allergen status;
- stability data; and
- application-specific performance data.
For oil ingredients, oxidation measurements can also be important.[3]
The important point is that the test should match the claim.
A product intended for oxidation protection should be supported by stability measurements. A product intended for sensory improvement should have appropriate sensory or application evidence. An ingredient intended to reduce interactions should be evaluated in a representative blend.
Examples of microencapsulated nutraceutical ingredients
Microencapsulation can be applied to a wide range of actives.
Within the NexaGens portfolio, examples include microencapsulated Coenzyme Q10 and carotenoids where protection and dispersibility can be formulation considerations, omega-3 fish oil and algal DHA oil powders for dry-format applications, and encapsulated iron forms where sensory characteristics or ingredient compatibility may be relevant.[4,5,6,7,8]
The best starting point is therefore not the technology name itself.
Start with the formulation problem:
What does the ingredient need to achieve inside the finished product?
Then identify the technical measurement that demonstrates whether the selected ingredient actually achieves it.
Choosing the right microencapsulated ingredient
Before qualifying a microencapsulated ingredient, formulators should be able to answer five questions:
- What formulation problem are we trying to solve?
- What measurable parameter demonstrates the required function?
- Does the supplier have data for this specific ingredient rather than only general technology claims?
- Is the ingredient immediate release or intentionally modified release?
- Is it suitable for our intended dosage form and manufacturing process?
Answering these questions makes supplier comparisons more meaningful and helps move the discussion from marketing terminology to measurable formulation performance.
Discuss your formulation with NexaGens
NexaGens supplies microencapsulated nutraceutical ingredients for formulation requirements including stability protection, sensory management, oil-to-powder conversion, dispersibility and ingredient compatibility.
If you are evaluating an ingredient for a new formulation, explore the NexaGens Microencapsulation technology platform and the current ingredient range, or contact the NexaGens team with your target active, dosage form and main formulation challenge.
Technical documentation and supporting data can then be reviewed as part of the ingredient qualification process.
References
1. Mehta N, Kumar P, Verma AK, Umaraw P, Kumar Y, Malav OP, Sazili AQ, Domínguez R, Lorenzo JM. Microencapsulation as a Noble Technique for the Application of Bioactive Compounds in the Food Industry: A Comprehensive Review. Applied Sciences. 2022;12(3):1424.
https://doi.org/10.3390/app12031424
2. Calderón-Oliver M, Ponce-Alquicira E. The Role of Microencapsulation in Food Application. Molecules. 2022;27(5):1499.
https://doi.org/10.3390/molecules27051499
3. da Silva LC, Castelo RM, Cheng HN, Biswas A, Furtado RF, Alves CR. Methods of Microencapsulation of Vegetable Oil: Principles, Stability and Applications—A Minireview. Food Technology and Biotechnology. 2022;60(3):308–320.
https://doi.org/10.17113/ftb.60.03.22.7329
4. NexaGens. Microencapsulation Technology.
https://nexagens.com/pages/microencapsulation
5. NexaGens. Stability Protection.
https://nexagens.com/pages/stability-protection
6. NexaGens. Solubility & Dispersibility Solutions.
https://nexagens.com/pages/solubility-and-dispersibility
7. NexaGens. Ingredient Interaction Protection.
https://nexagens.com/pages/ingredient-interaction-protection
8. NexaGens. Oil-to-Powder Ingredient Technology.
https://nexagens.com/pages/oil-to-powder-conversion